NRS 439.5272: Specifications of designated department governing reporting information to and accessing information.

If a system for the reporting of information on neurodegenerative diseases is established pursuant to NRS 439.5268, the designated department shall, in consultation with the Chief Medical Officer:

1. Prescribe the neurodegenerative diseases for which information may be reported in accordance with NRS 439.5274, which may include, without limitation, Parkinson’s disease, Parkinsonisms, multiple sclerosis and Alzheimer’s disease;

2. Prescribe the form and manner for reporting information on cases of neurodegenerative diseases and the information that may be included in each report; and

3. Establish protocol for allowing access to and preserving the confidentiality of the records of patients needed for research into neurodegenerative diseases.